Skip to main content
Top
Published in: Journal of Neurology 5/2015

01-05-2015 | Review

Diagnosis of muscle diseases presenting with early respiratory failure

Authors: Gerald Pfeffer, Marcus Povitz, G. John Gibson, Patrick F. Chinnery

Published in: Journal of Neurology | Issue 5/2015

Login to get access

Abstract

Here we describe a clinical approach and differential diagnosis for chronic muscle diseases which include early respiratory failure as a prominent feature in their presentation (i.e. respiratory failure whilst still ambulant). These patients typically present to neurology or respiratory medicine out-patient clinics and a distinct differential diagnosis of neuromuscular aetiologies should be considered. Amyotrophic lateral sclerosis and myasthenia gravis are the important non-muscle diseases to consider, but once these have been excluded there remains a challenging differential diagnosis of muscle conditions, which will be the focus of this review. The key points in the diagnosis of these disorders are being aware of relevant symptoms, which are initially caused by nocturnal hypoventilation or diaphragmatic weakness; and identifying other features which direct further investigation. Important muscle diseases to identify, because their diagnosis has disease-specific management implications, include adult-onset Pompe disease, inflammatory myopathy, and sporadic adult-onset nemaline myopathy. Cases which are due to metabolic myopathy or muscular dystrophy are important to diagnose because of their implications for genetic counselling. Myopathy from sarcoidosis and colchicine each has a single reported case with this presentation, but should be considered because they are treatable. Disorders which have recently had their genetic aetiologies identified include hereditary myopathy with early respiratory failure (due to TTN mutations), the FHL1-related syndromes, and myofibrillar myopathy due to BAG3 mutation. Recently described syndromes include oculopharyngodistal muscular dystrophy that awaits genetic characterisation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Laghi F, Tobin MJ (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168(1):10–48PubMedCrossRef Laghi F, Tobin MJ (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168(1):10–48PubMedCrossRef
2.
go back to reference Bourke SC, Gibson GJ (2002) Sleep and breathing in neuromuscular disease. Eur Respir J 19(6):1194–1201PubMedCrossRef Bourke SC, Gibson GJ (2002) Sleep and breathing in neuromuscular disease. Eur Respir J 19(6):1194–1201PubMedCrossRef
3.
go back to reference Rochester DF, Esau SA (1994) Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 15(4):751–763PubMed Rochester DF, Esau SA (1994) Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 15(4):751–763PubMed
4.
go back to reference Ambrosino N, Carpene N, Gherardi M (2009) Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 34(2):444–451PubMedCrossRef Ambrosino N, Carpene N, Gherardi M (2009) Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J 34(2):444–451PubMedCrossRef
5.
go back to reference Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med 8(5):597–619PubMedCentralPubMed Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med 8(5):597–619PubMedCentralPubMed
6.
go back to reference Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT (2007) Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 11(2):117–124PubMedCrossRef Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT (2007) Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 11(2):117–124PubMedCrossRef
7.
go back to reference American Thoracic Society/European Respiratory Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166(4):518–624CrossRef American Thoracic Society/European Respiratory Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166(4):518–624CrossRef
8.
go back to reference Hutchinson D, Whyte K (2008) Neuromuscular disease and respiratory failure. Pract Neurol 8(4):229–237PubMedCrossRef Hutchinson D, Whyte K (2008) Neuromuscular disease and respiratory failure. Pract Neurol 8(4):229–237PubMedCrossRef
9.
go back to reference Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11(4):379–382PubMedCrossRef Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11(4):379–382PubMedCrossRef
10.
go back to reference Qureshi AI, Choundry MA, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA et al (2004) Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit 10(12):CR684–CR689PubMed Qureshi AI, Choundry MA, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA et al (2004) Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit 10(12):CR684–CR689PubMed
11.
go back to reference Wang RY, Bodamer OA, Watson MS, Wilcox WR, ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases (2011) Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med 13(5):457–484PubMedCrossRef Wang RY, Bodamer OA, Watson MS, Wilcox WR, ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases (2011) Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med 13(5):457–484PubMedCrossRef
12.
go back to reference Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103(4):477–484PubMedCrossRef Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103(4):477–484PubMedCrossRef
13.
go back to reference Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884PubMedCrossRef Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884PubMedCrossRef
14.
go back to reference Muller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D et al (2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17(9–10):698–706PubMedCrossRef Muller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D et al (2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17(9–10):698–706PubMedCrossRef
15.
go back to reference American Association of Neuromuscular and Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40(1):149–160CrossRef American Association of Neuromuscular and Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40(1):149–160CrossRef
16.
go back to reference Goldstein JL, Young SP, Changela M, Dickerson GH, Zhang H, Dai J et al (2009) Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve 40(1):32–36PubMedCrossRef Goldstein JL, Young SP, Changela M, Dickerson GH, Zhang H, Dai J et al (2009) Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve 40(1):32–36PubMedCrossRef
17.
go back to reference Schoser BG, Muller-Hocker J, Horvath R, Gempel K, Pongratz D, Lochmuller H et al (2007) Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 33(5):544–559PubMed Schoser BG, Muller-Hocker J, Horvath R, Gempel K, Pongratz D, Lochmuller H et al (2007) Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 33(5):544–559PubMed
18.
go back to reference van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362(15):1396–1406PubMedCrossRef van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med 362(15):1396–1406PubMedCrossRef
19.
go back to reference Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R et al (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33(6):727–735PubMedCrossRef Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R et al (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33(6):727–735PubMedCrossRef
20.
go back to reference de Vries JM, van der Beek NA, Kroos MA, Ozkan L, van Doorn PA, Richards SM et al (2010) High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. Mol Genet Metab 101(4):338–345PubMedCrossRef de Vries JM, van der Beek NA, Kroos MA, Ozkan L, van Doorn PA, Richards SM et al (2010) High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa. Mol Genet Metab 101(4):338–345PubMedCrossRef
21.
go back to reference Kishnani PS, Goldenberg PC, DeArmey SL, Heller J, Benjamin D, Young S et al (2010) Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab 99(1):26–33PubMedCentralPubMedCrossRef Kishnani PS, Goldenberg PC, DeArmey SL, Heller J, Benjamin D, Young S et al (2010) Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab 99(1):26–33PubMedCentralPubMedCrossRef
22.
go back to reference Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35(1):70–77PubMedCrossRef Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35(1):70–77PubMedCrossRef
23.
go back to reference Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19PubMedCrossRef Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14–19PubMedCrossRef
24.
go back to reference Ravaglia S, Carlucci A, Danesino C (2010) Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: the two sides of low BMI. Mol Genet Metab 100(4):388PubMedCrossRef Ravaglia S, Carlucci A, Danesino C (2010) Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: the two sides of low BMI. Mol Genet Metab 100(4):388PubMedCrossRef
25.
go back to reference de Filippi P, Ravaglia S, Bembi B, Costa A, Moglia A, Piccolo G et al (2010) The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med 12(4):206–211PubMedCrossRef de Filippi P, Ravaglia S, Bembi B, Costa A, Moglia A, Piccolo G et al (2010) The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med 12(4):206–211PubMedCrossRef
27.
go back to reference Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V et al (2009) Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 66(1):85–91PubMedCrossRef Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V et al (2009) Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 66(1):85–91PubMedCrossRef
28.
go back to reference Pfeffer G, Sirrs S, Wade NK, Mezei MM (2011) Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci 38(1):119–123PubMedCrossRef Pfeffer G, Sirrs S, Wade NK, Mezei MM (2011) Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Can J Neurol Sci 38(1):119–123PubMedCrossRef
29.
go back to reference Smits BW, Heijdra YF, Cuppen FW, van Engelen BG (2011) Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol 258(11):2020–2025PubMedCentralPubMedCrossRef Smits BW, Heijdra YF, Cuppen FW, van Engelen BG (2011) Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia. J Neurol 258(11):2020–2025PubMedCentralPubMedCrossRef
30.
go back to reference Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M et al (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164(3):425–432PubMedCrossRef Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M et al (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164(3):425–432PubMedCrossRef
31.
go back to reference Bindoff LA, Howell N, Poulton J, McCullough DA, Morten KJ, Lightowlers RN et al (1993) Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem 268(26):19559–19564PubMed Bindoff LA, Howell N, Poulton J, McCullough DA, Morten KJ, Lightowlers RN et al (1993) Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem 268(26):19559–19564PubMed
32.
go back to reference Hadjigeorgiou GM, Kim SH, Fischbeck KH, Andreu AL, Berry GT, Bingham P et al (1999) A new mitochondrial DNA mutation (A3288G) in the tRNA(leu(UUR)) gene associated with familial myopathy. J Neurol Sci 164(2):153–157PubMedCrossRef Hadjigeorgiou GM, Kim SH, Fischbeck KH, Andreu AL, Berry GT, Bingham P et al (1999) A new mitochondrial DNA mutation (A3288G) in the tRNA(leu(UUR)) gene associated with familial myopathy. J Neurol Sci 164(2):153–157PubMedCrossRef
33.
go back to reference Yang CC, Hwang CC, Pang CY, Wei YH (1998) Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(leu(UUR))gene. J Formos Med Assoc 97(10):715–719PubMed Yang CC, Hwang CC, Pang CY, Wei YH (1998) Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(leu(UUR))gene. J Formos Med Assoc 97(10):715–719PubMed
34.
go back to reference Kleinle S, Schneider V, Moosmann P, Brandner S, Krahenbuhl S, Liechti-Gallati S (1998) A novel mitochondrial tRNA(phe) mutation inhibiting anticodon stem formation associated with a muscle disease. Biochem Biophys Res Commun 247(1):112–115PubMedCrossRef Kleinle S, Schneider V, Moosmann P, Brandner S, Krahenbuhl S, Liechti-Gallati S (1998) A novel mitochondrial tRNA(phe) mutation inhibiting anticodon stem formation associated with a muscle disease. Biochem Biophys Res Commun 247(1):112–115PubMedCrossRef
35.
go back to reference Goto Y, Tojo M, Tohyama J, Horai S, Nonaka I (1992) A novel point mutation in the mitochondrial tRNA(leu)(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 31(6):672–675PubMedCrossRef Goto Y, Tojo M, Tohyama J, Horai S, Nonaka I (1992) A novel point mutation in the mitochondrial tRNA(leu)(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 31(6):672–675PubMedCrossRef
36.
go back to reference Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsnia M, Wizer B (1992) Respiratory failure revealing mitochondrial myopathy in adults. Chest 101(3):824–828PubMedCrossRef Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsnia M, Wizer B (1992) Respiratory failure revealing mitochondrial myopathy in adults. Chest 101(3):824–828PubMedCrossRef
37.
go back to reference Desnuelle C, Pellissier JF, Serratrice G, Pouget J (1988) Chronic progressive external ophthalmoplegia (CPEO) associated with diaphragm paralysis: successful treatment with coenzyme Q (CoQ). Neurology 38(suppl):102 Desnuelle C, Pellissier JF, Serratrice G, Pouget J (1988) Chronic progressive external ophthalmoplegia (CPEO) associated with diaphragm paralysis: successful treatment with coenzyme Q (CoQ). Neurology 38(suppl):102
38.
go back to reference O’Brien A, Blaivas M, Albers J, Wald J, Watts C (1998) A case of respiratory muscle weakness due to cytochrome c oxidase enzyme deficiency. Eur Respir J 12(3):742–744PubMedCrossRef O’Brien A, Blaivas M, Albers J, Wald J, Watts C (1998) A case of respiratory muscle weakness due to cytochrome c oxidase enzyme deficiency. Eur Respir J 12(3):742–744PubMedCrossRef
39.
go back to reference Baker SK, Vladutiu GD, Peltier WL, Isackson PJ, Tarnopolsky MA (2008) Metabolic myopathies discovered during investigations of statin myopathy. Can J Neurol Sci 35(1):94–97PubMedCrossRef Baker SK, Vladutiu GD, Peltier WL, Isackson PJ, Tarnopolsky MA (2008) Metabolic myopathies discovered during investigations of statin myopathy. Can J Neurol Sci 35(1):94–97PubMedCrossRef
40.
go back to reference Manni R, Piccolo G, Banfi P, Cerveri I, Bruschi C, Zoia C et al (1991) Respiratory patterns during sleep in mitochondrial myopathies with ophthalmoplegia. Eur Neurol 31(1):12–17PubMedCrossRef Manni R, Piccolo G, Banfi P, Cerveri I, Bruschi C, Zoia C et al (1991) Respiratory patterns during sleep in mitochondrial myopathies with ophthalmoplegia. Eur Neurol 31(1):12–17PubMedCrossRef
41.
go back to reference Carroll JE, Zwillich C, Weil JV, Brooke MH (1976) Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 26(2):140–146PubMedCrossRef Carroll JE, Zwillich C, Weil JV, Brooke MH (1976) Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 26(2):140–146PubMedCrossRef
42.
go back to reference Barohn RJ, Clanton T, Sahenk Z, Mendell JR (1990) Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 40(1):103–106PubMedCrossRef Barohn RJ, Clanton T, Sahenk Z, Mendell JR (1990) Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 40(1):103–106PubMedCrossRef
43.
go back to reference Feit H, Kirkpatrick J, Van Woert MH, Pandian G (1983) Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan. Neurology 33(1):109–112PubMedCrossRef Feit H, Kirkpatrick J, Van Woert MH, Pandian G (1983) Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan. Neurology 33(1):109–112PubMedCrossRef
44.
go back to reference Tatsumi C, Takahashi M, Yorifuji S, Nishikawa Y, Kitaguchi M, Hashimoto S et al (1988) Mitochondrial encephalomyopathy with sleep apnea. Eur Neurol 28(2):64–69PubMedCrossRef Tatsumi C, Takahashi M, Yorifuji S, Nishikawa Y, Kitaguchi M, Hashimoto S et al (1988) Mitochondrial encephalomyopathy with sleep apnea. Eur Neurol 28(2):64–69PubMedCrossRef
45.
go back to reference Sembrano E, Barthlen GM, Wallace S, Lamm C (1997) Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 49(6):1714–1717PubMedCrossRef Sembrano E, Barthlen GM, Wallace S, Lamm C (1997) Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 49(6):1714–1717PubMedCrossRef
46.
go back to reference Voduc N, Webb KA, D’Arsigny C, McBride I, O’Donnell DE (2004) McArdle’s disease presenting as unexplained dyspnea in a young woman. Can Respir J 11(2):163–167PubMed Voduc N, Webb KA, D’Arsigny C, McBride I, O’Donnell DE (2004) McArdle’s disease presenting as unexplained dyspnea in a young woman. Can Respir J 11(2):163–167PubMed
47.
go back to reference Kiechl S, Willeit J, Vogel W, Kohlendorfer U, Poewe W (1999) Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9(6–7):408–410PubMedCrossRef Kiechl S, Willeit J, Vogel W, Kohlendorfer U, Poewe W (1999) Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9(6–7):408–410PubMedCrossRef
48.
go back to reference Kaminsky P, Poussel M, Pruna L, Deibener J, Chenuel B, Brembilla-Perrot B (2011) Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) 90(4):262–268CrossRef Kaminsky P, Poussel M, Pruna L, Deibener J, Chenuel B, Brembilla-Perrot B (2011) Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore) 90(4):262–268CrossRef
49.
go back to reference Jammes Y, Pouget J, Grimaud C, Serratrice G (1985) Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve 8(7):586–594PubMedCrossRef Jammes Y, Pouget J, Grimaud C, Serratrice G (1985) Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve 8(7):586–594PubMedCrossRef
50.
go back to reference Laberge L, Begin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S et al (2009) A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 80(6):642–646PubMedCrossRef Laberge L, Begin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S et al (2009) A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 80(6):642–646PubMedCrossRef
51.
go back to reference Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M et al (2011) Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case–control study. Sleep 34(2):165–170PubMedCentralPubMed Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M et al (2011) Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case–control study. Sleep 34(2):165–170PubMedCentralPubMed
52.
go back to reference Giubilei F, Antonini G, Bastianello S, Morino S, Paolillo A, Fiorelli M et al (1999) Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci 164(1):60–63PubMedCrossRef Giubilei F, Antonini G, Bastianello S, Morino S, Paolillo A, Fiorelli M et al (1999) Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci 164(1):60–63PubMedCrossRef
53.
go back to reference van der Meche FG, Bogaard JM, van der Sluys JC, Schimsheimer RJ, Ververs CC, Busch HF (1994) Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry 57(5):626–628PubMedCentralPubMedCrossRef van der Meche FG, Bogaard JM, van der Sluys JC, Schimsheimer RJ, Ververs CC, Busch HF (1994) Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry 57(5):626–628PubMedCentralPubMedCrossRef
54.
go back to reference Romigi A, Izzi F, Pisani V, Placidi F, Pisani LR, Marciani MG et al (2011) Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 18(9):1139–1145PubMedCrossRef Romigi A, Izzi F, Pisani V, Placidi F, Pisani LR, Marciani MG et al (2011) Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 18(9):1139–1145PubMedCrossRef
55.
go back to reference Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F (2010) Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 14(1):19–24PubMedCrossRef Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F (2010) Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath 14(1):19–24PubMedCrossRef
56.
go back to reference Nugent AM, Smith IE, Shneerson JM (2002) Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 121(2):459–464PubMedCrossRef Nugent AM, Smith IE, Shneerson JM (2002) Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 121(2):459–464PubMedCrossRef
57.
go back to reference Annane D, Moore DH, Barnes PR, Miller RG (2006) Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 3:CD003218PubMed Annane D, Moore DH, Barnes PR, Miller RG (2006) Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 3:CD003218PubMed
58.
go back to reference Orlikowski D, Chevret S, Quera-Salva MA, Laforet P, Lofaso F, Verschueren A et al (2009) Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther 31(8):1765–1773PubMedCrossRef Orlikowski D, Chevret S, Quera-Salva MA, Laforet P, Lofaso F, Verschueren A et al (2009) Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther 31(8):1765–1773PubMedCrossRef
59.
go back to reference Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R et al (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 53(4):537–542PubMedCrossRef Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R et al (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 53(4):537–542PubMedCrossRef
60.
go back to reference Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D et al (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60(8):1246–1251PubMedCrossRef Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D et al (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60(8):1246–1251PubMedCrossRef
61.
go back to reference Bourteel H, Vermersch P, Cuisset JM, Maurage CA, Laforet P, Richard P et al (2009) Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. J Neurol Neurosurg Psychiatry 80(12):1405–1408PubMedCrossRef Bourteel H, Vermersch P, Cuisset JM, Maurage CA, Laforet P, Richard P et al (2009) Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. J Neurol Neurosurg Psychiatry 80(12):1405–1408PubMedCrossRef
62.
go back to reference Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A et al (2005) Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol 62(12):1894–1899PubMedCrossRef Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A et al (2005) Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol 62(12):1894–1899PubMedCrossRef
63.
go back to reference Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C et al (2004) Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 56(5):738–741PubMedCrossRef Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C et al (2004) Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 56(5):738–741PubMedCrossRef
64.
go back to reference Patel ND, Jannapureddy SR, Hwang W, Chaudhry I, Boriek AM (2003) Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan-deficient mice. Am J Physiol Cell Physiol 284(4):C962–C968PubMedCrossRef Patel ND, Jannapureddy SR, Hwang W, Chaudhry I, Boriek AM (2003) Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan-deficient mice. Am J Physiol Cell Physiol 284(4):C962–C968PubMedCrossRef
65.
go back to reference Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S et al (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178–185PubMedCrossRef Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S et al (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178–185PubMedCrossRef
66.
go back to reference Walter MC, Dekomien G, Schlotter-Weigel B, Reilich P, Pongratz D, Muller-Felber W et al (2004) Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. Acta Myol 23(1):1–5PubMed Walter MC, Dekomien G, Schlotter-Weigel B, Reilich P, Pongratz D, Muller-Felber W et al (2004) Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. Acta Myol 23(1):1–5PubMed
68.
go back to reference Kley RA, Hellenbroich Y, van der Ven PF, Furst DO, Huebner A, Bruchertseifer V et al (2007) Clinical and morphological phenotype of the filamin myopathy: a study of 31 german patients. Brain 130(Pt 12):3250–3264PubMedCrossRef Kley RA, Hellenbroich Y, van der Ven PF, Furst DO, Huebner A, Bruchertseifer V et al (2007) Clinical and morphological phenotype of the filamin myopathy: a study of 31 german patients. Brain 130(Pt 12):3250–3264PubMedCrossRef
69.
go back to reference Walter MC, Reilich P, Huebner A, Fischer D, Schroder R, Vorgerd M et al (2007) Scapuloperoneal syndrome type kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 130(Pt 6):1485–1496PubMedCrossRef Walter MC, Reilich P, Huebner A, Fischer D, Schroder R, Vorgerd M et al (2007) Scapuloperoneal syndrome type kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 130(Pt 6):1485–1496PubMedCrossRef
70.
go back to reference Selcen D, Engel AG (2003) Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol 54(6):804–810PubMedCrossRef Selcen D, Engel AG (2003) Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol 54(6):804–810PubMedCrossRef
71.
go back to reference Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV et al (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65(1):83–89PubMedCentralPubMedCrossRef Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV et al (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65(1):83–89PubMedCentralPubMedCrossRef
72.
go back to reference Olive M, Odgerel Z, Martinez A, Poza JJ, Bragado FG, Zabalza RJ et al (2011) Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 21:533–542PubMedCrossRef Olive M, Odgerel Z, Martinez A, Poza JJ, Bragado FG, Zabalza RJ et al (2011) Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 21:533–542PubMedCrossRef
73.
go back to reference Boriek AM, Capetanaki Y, Hwang W, Officer T, Badshah M, Rodarte J et al (2001) Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol 280(1):C46–C52PubMed Boriek AM, Capetanaki Y, Hwang W, Officer T, Badshah M, Rodarte J et al (2001) Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol 280(1):C46–C52PubMed
74.
go back to reference Palmio J, Evila A, Chapon F, Tasca G, Xiang F, Bradvik B et al (2013) Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry 85(3):345–353 Palmio J, Evila A, Chapon F, Tasca G, Xiang F, Bradvik B et al (2013) Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry 85(3):345–353
75.
go back to reference Pfeffer G, Barresi R, Wilson IJ, Hardy SA, Griffin H, Hudson J et al (2014) Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry 85(3):331–338 Pfeffer G, Barresi R, Wilson IJ, Hardy SA, Griffin H, Hudson J et al (2014) Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry 85(3):331–338
76.
go back to reference Izumi R, Niihori T, Aoki Y, Suzuki N, Kato M, Warita H et al (2013) Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet 58(5):259–266 Izumi R, Niihori T, Aoki Y, Suzuki N, Kato M, Warita H et al (2013) Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet 58(5):259–266
77.
go back to reference Pfeffer G, Elliott HR, Griffin H, Barresi R, Miller J, Marsh J et al (2012) Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain 135(Pt 6):1695–1713PubMedCentralPubMedCrossRef Pfeffer G, Elliott HR, Griffin H, Barresi R, Miller J, Marsh J et al (2012) Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain 135(Pt 6):1695–1713PubMedCentralPubMedCrossRef
78.
go back to reference Ohlsson M, Hedberg C, Bradvik B, Lindberg C, Tajsharghi H, Danielsson O et al (2012) Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 135(Pt 6):1682–1694PubMedCrossRef Ohlsson M, Hedberg C, Bradvik B, Lindberg C, Tajsharghi H, Danielsson O et al (2012) Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 135(Pt 6):1682–1694PubMedCrossRef
79.
go back to reference Toro C, Olive M, Dalakas MC, Sivakumar K, Bilbao JM, Tyndel F et al (2013) Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol 13:29PubMedCentralPubMedCrossRef Toro C, Olive M, Dalakas MC, Sivakumar K, Bilbao JM, Tyndel F et al (2013) Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol 13:29PubMedCentralPubMedCrossRef
80.
go back to reference Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E et al (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308(5728):1599–1603PubMedCrossRef Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E et al (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308(5728):1599–1603PubMedCrossRef
81.
go back to reference Hedberg C, Melberg A, Dahlbom K, Oldfors A (2013) Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 137(Pt 4):e270 Hedberg C, Melberg A, Dahlbom K, Oldfors A (2013) Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 137(Pt 4):e270
82.
go back to reference Lehtokari VL, Pelin K, Donner K, Voit T, Rudnik-Schoneborn S, Stoetter M et al (2008) Identification of a founder mutation in TPM3 in nemaline myopathy patients of turkish origin. Eur J Hum Genet 16(9):1055–1061PubMedCrossRef Lehtokari VL, Pelin K, Donner K, Voit T, Rudnik-Schoneborn S, Stoetter M et al (2008) Identification of a founder mutation in TPM3 in nemaline myopathy patients of turkish origin. Eur J Hum Genet 16(9):1055–1061PubMedCrossRef
83.
go back to reference Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R et al (2008) Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 63(3):329–337PubMedCrossRef Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R et al (2008) Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 63(3):329–337PubMedCrossRef
84.
go back to reference Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C et al (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 10(2):249PubMed Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C et al (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 10(2):249PubMed
85.
go back to reference De Paula AM, Franques J, Fernandez C, Monnier N, Lunardi J, Pellissier JF et al (2009) A TPM3 mutation causing cap myopathy. Neuromuscul Disord 19(10):685–688PubMedCrossRef De Paula AM, Franques J, Fernandez C, Monnier N, Lunardi J, Pellissier JF et al (2009) A TPM3 mutation causing cap myopathy. Neuromuscul Disord 19(10):685–688PubMedCrossRef
86.
go back to reference Waddell LB, Kreissl M, Kornberg A, Kennedy P, McLean C, Labarre-Vila A et al (2010) Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3. Neuromuscul Disord 20(7):464–466PubMedCrossRef Waddell LB, Kreissl M, Kornberg A, Kennedy P, McLean C, Labarre-Vila A et al (2010) Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3. Neuromuscul Disord 20(7):464–466PubMedCrossRef
87.
go back to reference Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA et al (2010) Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 20(12):796–800PubMedCrossRef Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA et al (2010) Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 20(12):796–800PubMedCrossRef
88.
go back to reference Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH (2010) Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 31(2):176–183PubMedCentralPubMedCrossRef Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH (2010) Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 31(2):176–183PubMedCentralPubMedCrossRef
89.
go back to reference Cowling BS, Cottle DL, Wilding BR, D’Arcy CE, Mitchell CA, McGrath MJ (2011) Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21(4):237–251PubMedCrossRef Cowling BS, Cottle DL, Wilding BR, D’Arcy CE, Mitchell CA, McGrath MJ (2011) Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21(4):237–251PubMedCrossRef
90.
go back to reference Sarkozy A, Windpassinger C, Hudson J, Dougan CF, Lecky B, Hilton-Jones D et al (2011) Phenotypic heterogeneity in british patients with a founder mutation in the FHL1 gene. Eur J Hum Genet 19(10):1038–1044PubMedCentralPubMedCrossRef Sarkozy A, Windpassinger C, Hudson J, Dougan CF, Lecky B, Hilton-Jones D et al (2011) Phenotypic heterogeneity in british patients with a founder mutation in the FHL1 gene. Eur J Hum Genet 19(10):1038–1044PubMedCentralPubMedCrossRef
91.
go back to reference Selcen D, Bromberg MB, Chin SS, Engel AG (2011) Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology 77(22):1951–1959PubMedCentralPubMedCrossRef Selcen D, Bromberg MB, Chin SS, Engel AG (2011) Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology 77(22):1951–1959PubMedCentralPubMedCrossRef
92.
go back to reference Avram C, Angus R, Ford V, Ward K, Parker R (2011) XMPMA: acute on chronic ventilatory failure managed successfully with non-invasive ventilation. JRSM Short Rep 2(11):84PubMedCentralPubMedCrossRef Avram C, Angus R, Ford V, Ward K, Parker R (2011) XMPMA: acute on chronic ventilatory failure managed successfully with non-invasive ventilation. JRSM Short Rep 2(11):84PubMedCentralPubMedCrossRef
93.
go back to reference Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B et al (2008) An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82(1):88–99PubMedCentralPubMedCrossRef Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B et al (2008) An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82(1):88–99PubMedCentralPubMedCrossRef
94.
95.
go back to reference van der Sluijs BM, ter Laak HJ, Scheffer H, van der Maarel SM, van Engelen BG (2004) Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity. J Neurol Neurosurg Psychiatry 75(10):1499–1501PubMedCentralPubMedCrossRef van der Sluijs BM, ter Laak HJ, Scheffer H, van der Maarel SM, van Engelen BG (2004) Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity. J Neurol Neurosurg Psychiatry 75(10):1499–1501PubMedCentralPubMedCrossRef
96.
go back to reference Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M et al (2011) Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 76(3):227–235PubMedCrossRef Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M et al (2011) Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 76(3):227–235PubMedCrossRef
97.
go back to reference Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E et al (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15(1):32–39PubMedCrossRef Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E et al (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15(1):32–39PubMedCrossRef
98.
go back to reference Marie I, Hachulla E, Cherin P, Hellot MF, Herson S, Levesque H et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53(2):155–165PubMedCrossRef Marie I, Hachulla E, Cherin P, Hellot MF, Herson S, Levesque H et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53(2):155–165PubMedCrossRef
99.
go back to reference Kalluri M, Oddis CV (2010) Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 31(3):501–512PubMedCrossRef Kalluri M, Oddis CV (2010) Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 31(3):501–512PubMedCrossRef
100.
go back to reference Blumbergs PC, Byrne E, Kakulas BA (1984) Polymyositis presenting with respiratory failure. J Neurol Sci 65(2):221–229PubMedCrossRef Blumbergs PC, Byrne E, Kakulas BA (1984) Polymyositis presenting with respiratory failure. J Neurol Sci 65(2):221–229PubMedCrossRef
101.
go back to reference Sano M, Suzuki M, Sato M, Sakamoto T, Uchigata M (1994) Fatal respiratory failure due to polymyositis. Intern Med 33(3):185–187PubMedCrossRef Sano M, Suzuki M, Sato M, Sakamoto T, Uchigata M (1994) Fatal respiratory failure due to polymyositis. Intern Med 33(3):185–187PubMedCrossRef
102.
go back to reference Dejardin Botelho A, Perez T, Pouwels S, Wallaert B, Hachulla E, Tillie-Leblond I (2008) Inspiratory muscle myopathy and antisynthetase syndrome. Rev Med Intern 29(4):325–327CrossRef Dejardin Botelho A, Perez T, Pouwels S, Wallaert B, Hachulla E, Tillie-Leblond I (2008) Inspiratory muscle myopathy and antisynthetase syndrome. Rev Med Intern 29(4):325–327CrossRef
103.
go back to reference Selva-O’Callaghan A, Sanchez-Sitjes L, Munoz-Gall X, Mijares-Boeckh-Behrens T, Solans-Laque R, Angel Bosch-Gil J et al (2000) Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation. Rheumatology (Oxford) 39(8):914–916CrossRef Selva-O’Callaghan A, Sanchez-Sitjes L, Munoz-Gall X, Mijares-Boeckh-Behrens T, Solans-Laque R, Angel Bosch-Gil J et al (2000) Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation. Rheumatology (Oxford) 39(8):914–916CrossRef
104.
go back to reference Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M et al (2007) Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 26(11):1851–1855PubMedCrossRef Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M et al (2007) Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 26(11):1851–1855PubMedCrossRef
105.
go back to reference Cohen R, Lipper S, Dantzker DR (1993) Inclusion body myositis as a cause of respiratory failure. Chest 104(3):975–977PubMedCrossRef Cohen R, Lipper S, Dantzker DR (1993) Inclusion body myositis as a cause of respiratory failure. Chest 104(3):975–977PubMedCrossRef
106.
go back to reference Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST et al (2001) Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 50(3):312–320PubMedCrossRef Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST et al (2001) Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 50(3):312–320PubMedCrossRef
107.
go back to reference Chahin N, Selcen D, Engel AG (2005) Sporadic late onset nemaline myopathy. Neurology 65(8):1158–1164PubMedCrossRef Chahin N, Selcen D, Engel AG (2005) Sporadic late onset nemaline myopathy. Neurology 65(8):1158–1164PubMedCrossRef
108.
go back to reference Dalakas MC, Pezeshkpour GH, Flaherty M (1987) Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med 317(25):1602–1603PubMedCrossRef Dalakas MC, Pezeshkpour GH, Flaherty M (1987) Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med 317(25):1602–1603PubMedCrossRef
110.
go back to reference Gyure KA, Prayson RA, Estes ML (1997) Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med 121(11):1210–1213PubMed Gyure KA, Prayson RA, Estes ML (1997) Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med 121(11):1210–1213PubMed
111.
go back to reference Falga-Tirado C, Perez-Peman P, Ordi-Ros J, Bofill JM, Balcells E (1995) Adult onset of nemaline myopathy presenting as respiratory insufficiency. Respiration 62(6):353–354PubMedCrossRef Falga-Tirado C, Perez-Peman P, Ordi-Ros J, Bofill JM, Balcells E (1995) Adult onset of nemaline myopathy presenting as respiratory insufficiency. Respiration 62(6):353–354PubMedCrossRef
112.
go back to reference Kudou M, Kobayashi Y, Yamashita K, Kita H, Yasuba H, Hamada K (2006) Two cases of nemaline myopathy diagnosed after episodes of respiratory failure. Nihon Kokyuki Gakkai Zasshi 44(6):474–478PubMed Kudou M, Kobayashi Y, Yamashita K, Kita H, Yasuba H, Hamada K (2006) Two cases of nemaline myopathy diagnosed after episodes of respiratory failure. Nihon Kokyuki Gakkai Zasshi 44(6):474–478PubMed
113.
go back to reference Kelly E, Farrell MA, McElvaney NG (2008) Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care 53(11):1490–1494PubMed Kelly E, Farrell MA, McElvaney NG (2008) Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care 53(11):1490–1494PubMed
114.
go back to reference Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C et al (2001) Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord 11(1):35–40PubMedCrossRef Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C et al (2001) Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord 11(1):35–40PubMedCrossRef
115.
go back to reference de Sanctis JT, Cumbo-Nacheli G, Dobbie D, Baumgartner D (2008) HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS. AIDS Read. 18(2):90–94PubMed de Sanctis JT, Cumbo-Nacheli G, Dobbie D, Baumgartner D (2008) HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS. AIDS Read. 18(2):90–94PubMed
116.
go back to reference Dewberry RG, Schneider BF, Cale WF, Phillips LH 2nd (1993) Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve 16(8):832–835PubMedCrossRef Dewberry RG, Schneider BF, Cale WF, Phillips LH 2nd (1993) Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve 16(8):832–835PubMedCrossRef
117.
go back to reference Tanios MA, El Gamal H, Epstein SK, Hassoun PM (2004) Severe respiratory muscle weakness related to long-term colchicine therapy. Respir Care 49(2):189–191PubMed Tanios MA, El Gamal H, Epstein SK, Hassoun PM (2004) Severe respiratory muscle weakness related to long-term colchicine therapy. Respir Care 49(2):189–191PubMed
118.
go back to reference Simonds AK (2006) Recent advances in respiratory care for neuromuscular disease. Chest 130(6):1879–1886PubMedCrossRef Simonds AK (2006) Recent advances in respiratory care for neuromuscular disease. Chest 130(6):1879–1886PubMedCrossRef
119.
go back to reference Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140–147PubMedCrossRef Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140–147PubMedCrossRef
120.
go back to reference Guenther UP, Handoko L, Varon R, Stephani U, Tsao CY, Mendell JR et al (2009) Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease. J Mol Med 87(1):31–41PubMedCrossRef Guenther UP, Handoko L, Varon R, Stephani U, Tsao CY, Mendell JR et al (2009) Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease. J Mol Med 87(1):31–41PubMedCrossRef
121.
go back to reference Kyriakides T, Papacostas S, Papanicolaou E, Bagdades E, Papathanasiou ES (2011) Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block. Muscle Nerve 43(4):610–614PubMedCrossRef Kyriakides T, Papacostas S, Papanicolaou E, Bagdades E, Papathanasiou ES (2011) Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block. Muscle Nerve 43(4):610–614PubMedCrossRef
122.
go back to reference Gracey DR, Southorn PA (1987) Respiratory failure in lambert-eaton myasthenic syndrome. Chest 91(5):716–718PubMedCrossRef Gracey DR, Southorn PA (1987) Respiratory failure in lambert-eaton myasthenic syndrome. Chest 91(5):716–718PubMedCrossRef
123.
go back to reference Nicolle MW, Stewart DJ, Remtulla H, Chen R, Bolton CF (1996) Lambert-eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve 19(10):1328–1333PubMedCrossRef Nicolle MW, Stewart DJ, Remtulla H, Chen R, Bolton CF (1996) Lambert-eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve 19(10):1328–1333PubMedCrossRef
124.
go back to reference Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B et al (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 98(4):2017–2022PubMedCentralPubMedCrossRef Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B et al (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 98(4):2017–2022PubMedCentralPubMedCrossRef
125.
go back to reference Milone M, Shen XM, Selcen D, Ohno K, Brengman J, Iannaccone ST et al (2009) Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients. Neurology 73(3):228–235PubMedCentralPubMedCrossRef Milone M, Shen XM, Selcen D, Ohno K, Brengman J, Iannaccone ST et al (2009) Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients. Neurology 73(3):228–235PubMedCentralPubMedCrossRef
Metadata
Title
Diagnosis of muscle diseases presenting with early respiratory failure
Authors
Gerald Pfeffer
Marcus Povitz
G. John Gibson
Patrick F. Chinnery
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 5/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7526-1

Other articles of this Issue 5/2015

Journal of Neurology 5/2015 Go to the issue